Stocktoria
Aurinia Pharmaceuticals Inc. AUPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2001-07-16
Aurinia Pharmaceuticals Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 37.1% | -2.0% | -52.2% | -83.2% | -396.3% |
| Net margin | 101.5% | 2.4% | -44.5% | -80.7% | -396.8% |
| Return on assets | 38.2% | 1.0% | -14.2% | -23.0% | -33.3% |
| Return on equity | 49.4% | 1.5% | -20.6% | -26.7% | -37.8% |
| Current ratio | 5.25 | 4.57 | 5.50 | 9.60 | 12.63 |
| Revenue growth | 20.4% | 34.0% | 31.0% | 193.9% | -9.0% |
Source: SEC EDGAR filings · CIK 0001600620 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.